Oliver Lagore Vanvalin Investment Group Milestone Pharmaceuticals Inc. Transaction History
Oliver Lagore Vanvalin Investment Group
- $337 Million
- Q2 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 100 shares of MIST stock, worth $151. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$151
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
43Shares Held
30.2MCall Options Held
32.8KPut Options Held
0-
Black Rock Inc. New York, NY4.97MShares$7.51 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$4.92 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$4.15 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$4.01 Million1.58% of portfolio
-
Lion Point Capital, LP New York, NY2.34MShares$3.53 Million6.61% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $45.3M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...